http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2181285-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_946b2fadc5724c2f0ff70fce3f1f757c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
filingDate 1998-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2002-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54f3d66c77e8eb6ba7c47795dba89a11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5117dab89630835e875d7cf08b019f57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1793f769cc1f4cf68657f8c629e9d6cd
publicationDate 2002-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2181285-C2
titleOfInvention Gel system of nimesulide for topical use and method of its preparing (variants)
abstract FIELD: medicine, pharmacy. SUBSTANCE: invention relates to the preparation of nimesulide as gel for topical use for treatment of patients with skin inflammations. The preparation has 0.5-7 wt.-% of nimesulide, gel-forming agent, solvent, preserving agents and, if necessary, stabilizing agent and mixture of caprylic and capric acids esters with glycerol. Gel-forming agent is taken among 0.1-5 wt.-% of carboxyvinyl polymer neutralized with triethanolamine or diisopropanolamine an aqueous solution or 0.5-10 wt. -% of polyacrylamideisoparaffin. Solvent is taken among the group including ethanol, isopropanol and diethylene glycol monoethyl ester. The concentration of ethanol and isopropanol in preparation is from 5 to 20 wt.-%, diethylene glycol monoethyl ester is from 40 to 95 wt.-%. Method of preparing the preparation involves preparing an aqueous dispersed phase containing water-soluble preserving agents and carboxyvinyl polymer, addition of alcohol solvent, dispersing nimesulide, water-insoluble preserving agents and, if necessary, additions (moistening agents and enhancers of dermal sorption), neutralization of carboxyvinyl polymer with triethanolamine or diisopropanolamine an aqueous solution. The second variant of method involves preparing an aqueous phase, preparing organic phase, dispersing organic phase in aqueous phase and neutralization of carboxyvinyl polymer by addition of triethanolamine or diisopropanolamine. An aqueous phase has water-soluble preserving agents, mixture of caprylic and capric acids esters with glycerol and homogenously dispersed carboxyvinyl polymer. Organic phase has water-insoluble preserving agents, preferably a mixture of parabens, and nimesulide in diethylene glycol monoethyl ester. Use of nonwater solvents in preparing the gel system of nimesulide provides improvement of physical-chemical indices of preparation and indices of release and absorption of nimesulide based on its ability to dissolve dermal lipid barrier. EFFECT: improved method of preparing. 7 cl, 5 ex _
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2711090-C2
priorityDate 1997-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538089
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7618
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409282571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450006894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8086
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID38258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23675763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408813993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419568318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410494780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425953283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524027
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544893
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415763637
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 62.